159 related articles for article (PubMed ID: 22239180)
1. Prevalence of Coxiella burnetii antibodies among febrile patients in Croatia, 2008-2010.
Vilibic-Cavlek T; Kucinar J; Ljubin-Sternak S; Kolaric B; Kaic B; Lazaric-Stefanovic L; Hunjak B; Mlinaric-Galinovic G
Vector Borne Zoonotic Dis; 2012 Apr; 12(4):293-6. PubMed ID: 22239180
[TBL] [Abstract][Full Text] [Related]
2. Short communication: prevalence of antibodies against Coxiella burnetii (Q fever) in children in The Gambia, West Africa.
van der Hoek W; Sarge-Njie R; Herremans T; Chisnall T; Okebe J; Oriero E; Versteeg B; Goossens B; van der Sande M; Kampmann B; Nwakanma D
Trop Med Int Health; 2013 Jul; 18(7):850-3. PubMed ID: 23600611
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of Coxiella burnetii and Brucella seropositivities in patients presenting with acute fever].
Günal O; Barut S; Ayan M; Kılıç S; Duygu F
Mikrobiyol Bul; 2013 Apr; 47(2):265-72. PubMed ID: 23621726
[TBL] [Abstract][Full Text] [Related]
4. Q fever seroprevalence in metropolitan samples is similar to rural/remote samples in Queensland, Australia.
Tozer SJ; Lambert SB; Sloots TP; Nissen MD
Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1287-93. PubMed ID: 21499708
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of
van Roeden SE; Holsboer EW; Oosterheert JJ; van Kats JP; van Beckhoven J; Hogema BM; van Wijk MJ
Euro Surveill; 2018 Mar; 23(9):. PubMed ID: 29510781
[TBL] [Abstract][Full Text] [Related]
6. Adverse pregnancy outcomes and Coxiella burnetii antibodies in pregnant women, Denmark.
Nielsen SY; Mølbak K; Henriksen TB; Krogfelt KA; Larsen CS; Villumsen S
Emerg Infect Dis; 2014 Jun; 20(6):925-31. PubMed ID: 24856281
[TBL] [Abstract][Full Text] [Related]
7. Coxiella burnetii in humans and ticks in rural Senegal.
Mediannikov O; Fenollar F; Socolovschi C; Diatta G; Bassene H; Molez JF; Sokhna C; Trape JF; Raoult D
PLoS Negl Trop Dis; 2010 Apr; 4(4):e654. PubMed ID: 20386603
[TBL] [Abstract][Full Text] [Related]
8. The Sero-epidemiology of Coxiella burnetii in Humans and Cattle, Western Kenya: Evidence from a Cross-Sectional Study.
Wardrop NA; Thomas LF; Cook EA; de Glanville WA; Atkinson PM; Wamae CN; Fèvre EM
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005032. PubMed ID: 27716804
[TBL] [Abstract][Full Text] [Related]
9. Q fever seroprevalence in Australia suggests one in twenty people have been exposed.
Gidding HF; Peng CQ; Graves S; Massey PD; Nguyen C; Stenos J; Quinn HE; McIntyre PB; Durrheim DN; Wood N
Epidemiol Infect; 2020 Feb; 148():e18. PubMed ID: 32019623
[TBL] [Abstract][Full Text] [Related]
10. Short report: seroprevalence of human infection by Coxiella burnetii in Barcelona (northeast of Spain).
Cardeñosa N; Sanfeliu I; Font B; Muñoz T; Nogueras MM; Segura F
Am J Trop Med Hyg; 2006 Jul; 75(1):33-5. PubMed ID: 16837705
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of serum antibodies to Coxiella burnetii in Alaska Native Persons from the Pribilof Islands.
Kersh GJ; Fitzpatrick K; Pletnikoff K; Brubaker M; Bruce M; Parkinson A
Zoonoses Public Health; 2020 Feb; 67(1):89-92. PubMed ID: 31705592
[TBL] [Abstract][Full Text] [Related]
12. Estimated prevalence of chronic Q fever among Coxiella burnetii seropositive patients with an abdominal aortic/iliac aneurysm or aorto-iliac reconstruction after a large Dutch Q fever outbreak.
Hagenaars JC; Wever PC; van Petersen AS; Lestrade PJ; de Jager-Leclercq MG; Hermans MH; Moll FL; Koning OH; Renders NH
J Infect; 2014 Aug; 69(2):154-60. PubMed ID: 24647145
[TBL] [Abstract][Full Text] [Related]
13. High seroprevalence of Coxiella burnetii infection in Eastern Cantabria (Spain).
Pascual-Velasco F; Montes M; Marimón JM; Cilla G
Int J Epidemiol; 1998 Feb; 27(1):142-5. PubMed ID: 9563708
[TBL] [Abstract][Full Text] [Related]
14. The First Serological Study of Q Fever in Humans in Lebanon.
Dabaja MF; Greco G; Villari S; Bayan A; Vesco G; Gargano V; Arnone M; Hneino M; Lelli R; Ezzedine M; Berry A; Mortada H; Tempesta M; Mortada M
Vector Borne Zoonotic Dis; 2018 Mar; 18(3):138-143. PubMed ID: 29336692
[TBL] [Abstract][Full Text] [Related]
15. Febrile patients admitted to remote hospitals in Northeastern Kenya: seroprevalence, risk factors and a clinical prediction tool for Q-Fever.
Njeru J; Henning K; Pletz MW; Heller R; Forstner C; Kariuki S; Fèvre EM; Neubauer H
BMC Infect Dis; 2016 Jun; 16():244. PubMed ID: 27260261
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Coxiella burnetii in a healthy population from northern Greece.
Pape M; Mandraveli K; Nikolaidis P; Alexiou-Daniel S; Arvanitidou-Vagiona M
Clin Microbiol Infect; 2009 Dec; 15 Suppl 2():148-9. PubMed ID: 19456803
[No Abstract] [Full Text] [Related]
17. Absence of convincing evidence of Coxiella burnetii infection in Chile: a cross-sectional serosurvey among healthy adults in four different regions.
Weitzel T; López J; Acosta-Jamett G; Edouard S; Parola P; Abarca K
BMC Infect Dis; 2016 Oct; 16(1):541. PubMed ID: 27716089
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and clinical features of human infection with Coxiella burnetii in Denmark during 2006-07.
Bacci S; Villumsen S; Valentiner-Branth P; Smith B; Krogfelt KA; Mølbak K
Zoonoses Public Health; 2012 Feb; 59(1):61-8. PubMed ID: 21824371
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of Coxiella burnetii prevalence in women who had miscarriage and their spouses by serological and molecular methods].
Eyigör M; Gültekin B; Telli M; Odabaşı AR; Yüksel H; Demircan Sezer S; Aydın N
Mikrobiyol Bul; 2013 Apr; 47(2):324-31. PubMed ID: 23621732
[TBL] [Abstract][Full Text] [Related]
20. Q fever in young children, Ghana.
Kobbe R; Kramme S; Kreuels B; Adjei S; Kreuzberg C; Panning M; Adjei O; Fleischer B; May J
Emerg Infect Dis; 2008 Feb; 14(2):344-6. PubMed ID: 18258140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
